What are the Historical Developments and Current Growth Metrics of the Infusion Therapy Devices Market?
The infusion therapy devices market has seen considerable growth due to a variety of factors.
• The market for infusion therapy devices has seen a significant surge in size in the past few years. It is projected to expand from $12.10 billion in 2024 to $13.43 billion in 2025, with a compound annual growth rate (CAGR) of 11.0%.
Factors such as growing hospital admissions, advancements in healthcare infrastructure, government efforts, medical tourism, and insurance refund policies have all contributed to this historical growth phase.
What is the Forecasted Market Size and CAGR for the Infusion Therapy Devices Market?
The infusion therapy devices market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for infusion therapy devices is projected to witness swift expansion in the upcoming years, reaching a $20.11 billion value by 2029 with a compound annual growth rate (CAGR) of 10.6%.
The predicted growth during this period can be credited to the influence of personalized medicine, readiness for and response to pandemics, the use of wearable infusion devices, a shift towards infusion therapy, and the digitalization of healthcare. Key emerging trends for this forecast period will include 5G networking, quantum computing, integration of Internet of Things (IoT), wearable health technologies, and the advent of voice assistants with natural language processing.
What Factors Are Driving Growth In The Infusion Therapy Devices Market?
The surge in chronic illnesses is anticipated to stimulate the expansion of the infusion therapy devices market in the future. Chronic illnesses are long-term health issues that last for over a year, necessitating regular medical care or impacting daily life activities. The surge in chronic illnesses can be accredited to poor lifestyle decisions, lack of physical activity, unhealthy eating habits, and environmental factors, along with the climbing risk factors such as obesity, smoking, and stress. Infusion therapy devices offer a solution to managing chronic illnesses by facilitating regulated, precise delivery of drugs and fluids right into the bloodstream. This ensures consistent and potent treatment for diseases such as diabetes, autoimmune disorders, and cancer, thus improving patient results, raising convenience, and decreasing the necessity for repeated hospital visits. For instance, data from the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, in January 2023 projected that by 2050, the count of individuals aged 50 years and above suffering from at least one chronic ailment will rise by 99.5%, increasing from 71.522 million in 2020 to 142.66 million. Consequently, the escalating prevalence of chronic diseases is fueling the growth of the infusion therapy devices market.
What are the Market Segments in the Infusion Therapy Devices Market?
The infusion therapy devices market covered in this report is segmented –
1) By Product: Infusion Pumps, Intravenous (Iv) Sets, Cannulas, Needleless Connectors
2) By Mobility: Portable Infusion Pumps, Stationary Pumps
3) By Application: Oncology, Diabetes, Pain Management, Other Applications
4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare, Other End-Users
Subsegments:
1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Infusion Pumps
2) By Intravenous (IV) Sets: Standard IV Sets, Extension IV Sets, IV Administration Sets with Filters
3) By Cannulas: Peripheral Intravenous (PIV) Cannulas, Central Venous Cannulas, Butterfly Cannulas
4) By Needleless Connectors: Positive Pressure Needleless Connectors, Neutral Pressure Needleless Connectors, Negative Pressure Needleless Connectors
Pre-Book The Infusion Therapy Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends are Shaping the Infusion Therapy Devices Market?
Key players in the infusion therapy device industry are shifting their focus towards the creation of cutting-edge tools such as pressure-enabled drug delivery (PEDD) technology to improve the handling of liver and pancreatic cancer. PEDD is an advanced drug delivery technology that utilizes pressure to accelerate the supply of medicinal agents into tissues or organs, especially in areas where standard methods might face hindrances. For example, TriSalus Life Sciences, a medical technology corporation from the United States, released the TriNav LV Infusion System and TriGuide Guiding Catheters in November 2024, thereby growing their PEDD range to refine therapeutic delivery and possibly enhance patient outcomes. The TriNav LV Infusion System includes exclusive traits such as larger blood vessels (3.5 to 5.0 mm), thereby extending the utility of TriSalus' PEDD technology to a wider patient group. This new availability of the PEDD device now accommodates vessel sizes from 1.5 mm to 5.0 mm, providing more choices for interventional radiologists. TriGuide Guiding Catheters come with a bigger internal diameter, a slick lining, and a reverse curve format to streamline femoral access and boost procedural efficiency. Preliminary users have noted a 97% satisfaction rate, emphasizing the system's efficacy and user-friendliness in cancer treatments.
Who Are the Key Players in the Infusion Therapy Devices Market?
Major companies operating in the infusion therapy devices market are include:
• Roche Holding AG
• Fresenius Kabi AG
• Medtronic plc
• Medline Industries Inc.
• Baxter International Inc.
• Terumo Corporation
• Mindray Medical International Limited
• Nipro Corporation
• ICU Medical Inc.
• Cook Medical
• Acelity L.P Inc.
• LivaNova PLC
• Vygon S.A.
• AngioDynamics Inc.
• B. Braun Melsungen AG
• Moog Medical Devices Group
• Kangaroo
• Vantage Medical Technologies
• Alaris Medical Systems Inc.
• AccuVein Inc.
What are the Regional Insights into the Infusion Therapy Devices Market?
North America was the largest region in the infusion therapy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
